美股新聞 標題聯播 · 近 24 小時 336 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · SLP近 30 天 1 則 · 第 1 / 1 頁
- Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch
- Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
- Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
- [Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit
- Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls
- Altaris to acquire Simulations Plus in $375m all-cash deal
- Simulations Plus to Be Acquired by Altaris For Approximately $375 Million
- Dividend Investors: Don't Be Too Quick To Buy SLP Resources Berhad (KLSE:SLP) For Its Upcoming Dividend
- How The Investment Story Is Evolving For Sylvania Platinum (AIM:SLP)
- Is It Too Late To Consider Buying Simulations Plus, Inc. (NASDAQ:SLP)?
- PTC Q2 Earnings & Revenues Beat on AI-Led ARR Strength, Shares Jump
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。